Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gender differences with short-term vs 12 months dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-years follow-up results of the REDUCE trial.
Verdoia M, Suryapranata H, Damen S, Camaro C, Benit E, Barbieri L, Rasoul S, Liew HB, Polad J, Ahmad WAW, Zambahari R, Lalmand J, van der Schaaf RJ, Koh TH, Timmermans P Sr, Dilling-Boer D, Veenstra LF, Van't Hof AWJ, Lee SWL, Roolvink V, Ligtenberg E, Postma S, Kolkman EJJ, Brouwer MA, Kedhi E, De Luca G. Verdoia M, et al. Among authors: van t hof awj, van der schaaf rj. J Thromb Thrombolysis. 2021 Oct;52(3):797-807. doi: 10.1007/s11239-021-02439-x. Epub 2021 Apr 13. J Thromb Thrombolysis. 2021. PMID: 33847862 Clinical Trial.
A prospective, postmarket study with the Mguard Prime Embolic Protection Stent in ST-segment elevation myocardial infarction: the International MGuard Prime Observational Study (IMOS Prime).
Amoroso G, Vos NS, Van der Heyden JA, van der Schaaf RJ, Patterson MS, Vink MA, Herrman JP, Slagboom T. Amoroso G, et al. Among authors: van der heyden ja, van der schaaf rj. Catheter Cardiovasc Interv. 2015 Oct;86 Suppl 1:S28-33. doi: 10.1002/ccd.25914. Epub 2015 Mar 24. Catheter Cardiovasc Interv. 2015. PMID: 25754236
Paclitaxel-eluting balloon versus everolimus-eluting stent in patients with diabetes mellitus and in-stent restenosis: Insights from the randomized DARE trial.
Claessen BE, Henriques JPS, Vendrik J, Boerlage-van Dijk K, van der Schaaf RJ, Meuwissen M, van Royen N, Gosselink ATM, van Wely MH, Dirkali A, Arkenbout EK, Piek JJ, Baan J Jr. Claessen BE, et al. Among authors: van royen n, van wely mh, van der schaaf rj. Catheter Cardiovasc Interv. 2019 Feb 1;93(2):216-221. doi: 10.1002/ccd.27814. Epub 2018 Sep 19. Catheter Cardiovasc Interv. 2019. PMID: 30232824 Clinical Trial.
Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug-eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease-AIDA trial substudy.
Tijssen RYG, van der Schaaf RJ, Kraak RP, Vink MA, Hofma SH, Arkenbout EK, Weevers APJD, Kerkmeijer LSM, Onuma Y, Serruys PW, Beijk MAM, Koch KT, Baan J Jr, Vis MM, Piek JJ, Tijssen JGP, Henriques JPS, de Winter RJ, Wykrzykowska JJ. Tijssen RYG, et al. Among authors: van der schaaf rj. Catheter Cardiovasc Interv. 2020 Jan;95(1):89-96. doi: 10.1002/ccd.28193. Epub 2019 Apr 9. Catheter Cardiovasc Interv. 2020. PMID: 30968559 Clinical Trial.
Sex differences in characteristics and outcome in acute coronary syndrome patients in the Netherlands.
Ten Haaf ME, Bax M, Ten Berg JM, Brouwer J, Van't Hof AW, van der Schaaf RJ, Stella PR, Tjon Joe Gin RM, Tonino PA, de Vries AG, Zijlstra F, Boersma E, Appelman Y. Ten Haaf ME, et al. Among authors: van t hof aw, van der schaaf rj. Neth Heart J. 2019 May;27(5):263-271. doi: 10.1007/s12471-019-1271-0. Neth Heart J. 2019. PMID: 30989470 Free PMC article.
Outcomes of bioresorbable vascular scaffolds versus everolimus-eluting stents by coronary complexity: a sub-analysis of the AIDA trial.
Kraak RP, Tijssen RYG, van Dongen IM, Elias J, Hofma SH, van der Schaaf RJ, Arkenbout EK, Weevers A, Tijssen JGP, Piek JJ, de Winter RJ, Henriques JPS, Wykrzykowska JJ; Collaborators. Kraak RP, et al. Among authors: van der schaaf rj, van dongen im. EuroIntervention. 2020 Dec 4;16(11):e904-e912. doi: 10.4244/EIJ-D-18-00884. EuroIntervention. 2020. PMID: 31062692 Free article.
Complex Large-Bore Radial percutaneous coronary intervention: rationale of the COLOR trial study protocol.
Meijers TA, Aminian A, Teeuwen K, van Wely M, Schmitz T, Dirksen MT, van der Schaaf RJ, Iglesias JF, Agostoni P, Dens J, Knaapen P, Rathore S, Ottervanger JP, Dambrink JE, Roolvink V, Gosselink ATM, Hermanides RS, van Royen N, van Leeuwen MAH. Meijers TA, et al. Among authors: van royen n, van wely m, van leeuwen mah, van der schaaf rj. BMJ Open. 2020 Jul 20;10(7):e038042. doi: 10.1136/bmjopen-2020-038042. BMJ Open. 2020. PMID: 32690749 Free PMC article.
An immediate or early invasive strategy in non-ST-elevation acute coronary syndrome: The OPTIMA-2 randomized controlled trial.
Fagel ND, Amoroso G, Vink MA, Slagboom T, van der Schaaf RJ, Herrman JP, Patterson MS, Oosterwerff EFJ, Vos NS, Verheugt FWA, Tijssen JGP, de Winter RJ, Riezebos RK. Fagel ND, et al. Among authors: van der schaaf rj. Am Heart J. 2021 Apr;234:42-50. doi: 10.1016/j.ahj.2021.01.001. Epub 2021 Jan 7. Am Heart J. 2021. PMID: 33422517 Clinical Trial.
108 results